tiprankstipranks
Top Stocks
Top Analyst StocksTop Smart Score StocksTop Insiders Stocks
Popular
Stock ScreenerTop Online Growth StocksTrending StocksPenny Stock Screener
Dividend Investing
Dividend CalculatorDividend Yield CalculatorDividend StocksDividend NewsDividend Calendar
ETFs
ETF CenterSPY ETFQQQ ETF
Stock Comparison
ChatGPT StocksValue StocksAirline StocksAI StocksOil StocksBank StocksFAANG StocksCompare More Stocks…
Calendars
IPO CalendarEarnings Calendar
Popular
Dividend CalendarEconomic Calendar
New
Market HolidaysDaily Analyst RatingsDaily Insider Trading
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Stock Market NewsStock Analysis & Ideas
Popular
ETF NewsGlobal Markets NewsExpert SpotlightTipRanks LabsEarnings Reports InsightsMarket BreakdownsDividend Stock NewsCrypto News
My PortfolioMy PerformanceMy Portfolio AnalysisCrowd InsightsMy Watchlist
About Us
About TipRanksContact Us
Working with TipRanks
Enterprise SolutionsBest Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert Center
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
ETF Center
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Smart Score Stocks
Analysts' Hot Stocks
Insiders' Hot Stocks
Popular
Trending Stocks
Fastest Growing Websites
Hot
Penny Stocks
Market Movers
My Experts
Top Firms
Top Wall Street Analysts
Top Financial Bloggers
Top Corporate Insiders
Popular
Top Hedge Fund Managers
Top Individual Investors
Stock Screener
Stock Comparison
Dividend Calculator
Popular
ETF Center
Dividend Yield Calculator
Daily Stock Ratings
Daily Insider Transactions
Stock ComparisonPOPULAR COMPARISONS
Dividend Stocks
ChatGPT Stocks
Airline Stocks
AI Stocks
My Portfolio
My Performance
My Portfolio Analysis
Crowd Insights
Earnings Calendar
Popular
Dividend Calendar
Economic Calendar
New
IPO Calendar
Stock Market Holidays
Market News
ETF News
Stock Analysis & Ideas
Popular
Global Markets News
Expert Spotlight
Tipranks Labs
Earnings Reports Insights
Market Breakdowns
Dividend Stock News
Crypto News
About TipRanks
For Business
Become an Affiliate
Reviews
Contact Us
Plans & Pricing

NTLA Stock Latest News

Intellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to NTLA-2002 for the Treatment of Hereditary Angioedema
Press ReleasesIntellia Therapeutics Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to NTLA-2002 for the Treatment of Hereditary Angioedema
3d ago
NTLA
Intellia Therapeutics announces FDA granted RMAT to NTLA-2002
The FlyIntellia Therapeutics announces FDA granted RMAT to NTLA-2002
3d ago
NTLA
Intellia Therapeutics initiated with an Outperform at Bernstein
The FlyIntellia Therapeutics initiated with an Outperform at Bernstein
3d ago
NTLA
Intellia Therapeutics upgraded to Outperform from Market Perform at BMO Capital
The FlyIntellia Therapeutics upgraded to Outperform from Market Perform at BMO Capital
11d ago
NTLA
“Strong Buy” Intellia Therapeutics Stock (NASDAQ:NTLA) Still Requires Prudence
Stock Analysis & Ideas“Strong Buy” Intellia Therapeutics Stock (NASDAQ:NTLA) Still Requires Prudence
16d ago
NTLA
Intellia Therapeutics announces FDA clearance of IND for NTLA-2002
The FlyIntellia Therapeutics announces FDA clearance of IND for NTLA-2002
22d ago
NTLA
Intellia Therapeutics price target lowered to $111 from $129 at Chardan
The FlyIntellia Therapeutics price target lowered to $111 from $129 at Chardan
28d ago
NTLA
Intellia Therapeutics price target lowered to $42 from $58 at Baird
The FlyIntellia Therapeutics price target lowered to $42 from $58 at Baird
28d ago
NTLA
Intellia Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Company Progress
Press ReleasesIntellia Therapeutics Announces Fourth Quarter and Full-Year 2022 Financial Results and Highlights Recent Company Progress
29d ago
NTLA
Intellia Therapeutics reports Q4 EPS ($1.40), consensus ($1.39)
The FlyIntellia Therapeutics reports Q4 EPS ($1.40), consensus ($1.39)
29d ago
NTLA
Intellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2022 Earnings and Company Updates
Press ReleasesIntellia Therapeutics to Hold Conference Call to Discuss Fourth Quarter and Full-Year 2022 Earnings and Company Updates
1M ago
NTLA
2 High-Risk, High-Reward Stock Bets Cathie Wood Is Taking Into 2023
Stock Analysis & Ideas2 High-Risk, High-Reward Stock Bets Cathie Wood Is Taking Into 2023
2M ago
NTLA
VERV
Intellia Therapeutics initiated with an Overweight at Cantor Fitzgerald
The FlyIntellia Therapeutics initiated with an Overweight at Cantor Fitzgerald
2M ago
NTLA
Intellia Therapeutics upgraded to Neutral from Sell at Citi
The FlyIntellia Therapeutics upgraded to Neutral from Sell at Citi
2M ago
NTLA
JMP downgrades Intellia on lack of 2023 clinical updates
The FlyJMP downgrades Intellia on lack of 2023 clinical updates
2M ago
NTLA
Intellia Therapeutics downgraded to Market Perform from Outperform at JMP Securities
The FlyIntellia Therapeutics downgraded to Market Perform from Outperform at JMP Securities
2M ago
NTLA
Intellia awarded innovation passport in UK for NTLA-2002
The FlyIntellia awarded innovation passport in UK for NTLA-2002
2M ago
NTLA
Intellia Therapeutics Awarded Innovation Passport in the United Kingdom for NTLA-2002, an Investigational Genome Editing Treatment for Hereditary Angioedema
Press ReleasesIntellia Therapeutics Awarded Innovation Passport in the United Kingdom for NTLA-2002, an Investigational Genome Editing Treatment for Hereditary Angioedema
2M ago
NTLA
ZM, NTLA, or SQ: Which Cathie Wood ARKK Stock Is Most Appealing in 2023?
Stock Analysis & IdeasZM, NTLA, or SQ: Which Cathie Wood ARKK Stock Is Most Appealing in 2023?
3M ago
SQ
ZM
Intellia Therapeutics highlights strategic priorities, milestones for 2023
The FlyIntellia Therapeutics highlights strategic priorities, milestones for 2023
3M ago
NTLA
Intellia Therapeutics Highlights Strategic Priorities and Anticipated 2023 Key Milestones
Press ReleasesIntellia Therapeutics Highlights Strategic Priorities and Anticipated 2023 Key Milestones
3M ago
NTLA
Intellia Therapeutics to participate in a conference call with JPMorgan
The FlyIntellia Therapeutics to participate in a conference call with JPMorgan
4M ago
NTLA
Intellia Therapeutics 6.55M share Spot Secondary priced at $45.80
The FlyIntellia Therapeutics 6.55M share Spot Secondary priced at $45.80
4M ago
NTLA
Here’s Why Intellia (NASDAQ:NTLA) Stock Is Trending Lower
Market NewsHere’s Why Intellia (NASDAQ:NTLA) Stock Is Trending Lower
4M ago
NTLA
Intellia Therapeutics to participate in a conference call with JPMorgan
The FlyIntellia Therapeutics to participate in a conference call with JPMorgan
4M ago
NTLA
Intellia Therapeutics Announces Pricing of Public Offering of Common Stock
Press ReleasesIntellia Therapeutics Announces Pricing of Public Offering of Common Stock
4M ago
NTLA
Intellia Therapeutics $250M Spot Secondary; price range $45.80-$47.80
The FlyIntellia Therapeutics $250M Spot Secondary; price range $45.80-$47.80
4M ago
NTLA
Intellia Therapeutics announces $250M common stock offering
The FlyIntellia Therapeutics announces $250M common stock offering
4M ago
NTLA
Intellia Therapeutics Announces Proposed Public Offering of Common Stock
Press ReleasesIntellia Therapeutics Announces Proposed Public Offering of Common Stock
4M ago
NTLA